Literature DB >> 7787724

Multilocular cystic renal cell carcinoma presenting as a solid mass: radiologic evaluation.

Y Yamashita1, T Miyazaki, A Ishii, O Watanabe, M Takahashi.   

Abstract

BACKGROUND: Multilocular cystic renal cell carcinomas (MCRCCs) are a recently described variety of renal cell carcinoma with characteristic pathological and clinical features. We found that the radiologic appearances of MCRCCs of smaller size did not fulfill the previously documented criteria of the MCRCCs. This study was conducted to analyze the radiologic characteristics of MCRCCs of smaller sizes.
METHODS: The radiologic findings of 13 multilocular cystic renal cell carcinomas of diameter ranging from 10-32 mm (average 22 mm) seen in nine patients were analyzed in correlation with pathologic findings.
RESULTS: On US, the tumors were predominantly hyperechoic (11 of 13 tumors) with or without small anechoic areas. Precontrast CT showed the lesions to be either hypodense or hyperdense depending on the presence of hemorrhage. Degree of contrast enhancement was usually slight. The mean increase in CT attenuation was 28 +/- 19 (mean +/- standard deviation) at dynamic phase and 12 +/- 10 at delayed phase. On MR imaging, signal intensities of the tumors were high both on T1- and T2-weighted images (7 of 9 tumors) due to proteinaceous fluid or hemorrhage. Dynamic enhanced MR imaging revealed irregular contrast enhancement within the tumor (5 of 6 tumors). Angiography failed to reveal neovascularity.
CONCLUSION: Although multiple cysts were seen within the tumors pathologically, MCRCCs of smaller sizes appeared solid on radiologic examinations. However, contrast enhancement or neovascularity was very slight.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787724     DOI: 10.1007/bf00201530

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  8 in total

Review 1.  The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies.

Authors:  M A Bosniak
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

2.  Multilocular cystic renal cell carcinoma.

Authors:  M A Feldberg; P F van Waes
Journal:  AJR Am J Roentgenol       Date:  1982-05       Impact factor: 3.959

3.  Cystic adenocarcinoma of the kidney mimicking multilocular renal cyst.

Authors:  J S Wills
Journal:  Urol Radiol       Date:  1983

4.  Renal cyst versus tumor: a continuing dilemma.

Authors:  J B Murphy; F F Marshall
Journal:  J Urol       Date:  1980-04       Impact factor: 7.450

5.  Renal cell carcinoma: dynamic thin-section CT assessment of vascular invasion and tumor vascularity.

Authors:  R K Zeman; J J Cronan; A T Rosenfield; J H Lynch; M H Jaffe; L R Clark
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

6.  Multilocular cystic renal cell carcinoma.

Authors:  T Murad; W Komaiko; R Oyasu; K Bauer
Journal:  Am J Clin Pathol       Date:  1991-05       Impact factor: 2.493

7.  Papillary renal cell carcinoma: CT and sonographic evaluation.

Authors:  G A Press; B L McClennan; G L Melson; P J Weyman; M A Mauro; J K Lee
Journal:  AJR Am J Roentgenol       Date:  1984-11       Impact factor: 3.959

8.  Cystic renal cell carcinoma.

Authors:  D S Hartman; C J Davis; T Johns; S M Goldman
Journal:  Urology       Date:  1986-08       Impact factor: 2.649

  8 in total
  3 in total

1.  CT and US findings of multilocular cystic renal cell carcinoma.

Authors:  J C Kim; K H Kim; J W Lee
Journal:  Korean J Radiol       Date:  2000 Apr-Jun       Impact factor: 3.500

2.  Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma.

Authors:  Shanwen Chen; Baiye Jin; Liqi Xu; Guanghou Fu; Hongzhou Meng; Ben Liu; Jun Li; Dan Xia
Journal:  BMC Urol       Date:  2014-11-07       Impact factor: 2.264

3.  Magnetic resonance imaging for rapid screening for the nephrotoxic and hepatotoxic effects of microcystins.

Authors:  Aleksandra Milutinović; Ruda Zorc-Pleskovič; Marko Živin; Andrej Vovk; Igor Serša; Dušan Šuput
Journal:  Mar Drugs       Date:  2013-08-05       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.